The new facility will produce biologic drugs and Keytruda, becoming Merck’s first in-house US site to make the blockbuster cancer treatment, the company said.

Summer begins early in Hollywood, on the first weekend in May and that kick-off can make or break that pivotal 123 day ...

Key Takeaways Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...

Attorney General Pam Bondi traveled to a Drug Enforcement Administration lab to meet with chemists who are tasked with ...

DC isn’t the only place where regulatory burden-boosting policy proposals are garnering bipartisan support. The same ...

We do not see JD Health to be in any financial distress. The balance sheet has CNY 200 million of debt compared with CNY 40 billion of cash and equivalents and almost no debt as of Dec. 31, 2024. The ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...

Imagine materials that build themselves, responding intelligently to their environment to deliver drugs precisely where needed, scaffold regenerating tissues, or clean up pollutants. These are the ...

Guernsey County Sheriff Jeff Paden announced significant prison sentences for three individuals involved in high-level drug ...

Major scientific discoveries can arise from simple decisions: say, by simply looking where virtually no one else has. Such ...